BeyondSpring Inc. (BYSI)Healthcare | Biotechnology | Florham Park, United States | NasdaqCM
1.74 USD
-0.04
(-1.988%) ⇩
(April 21, 2026, 12:21 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 6:33 p.m. EDT
BeyondSpring is a long-term fundamental trap ($32M debt vs $144WOO cash as interpreted from context, or rather, a balance sheet with negative book value of -$0.798 and negative EPS—but with a massive 88-short ratio bullish signal) dragging it down. Technically, the massive short ratio implies a potential short squeeze, and the options flow is overcrowded to the upside, attempting to pin the stock at $2.50. Until there is real营收 (revenue growth) or a massive re-rating from the cash position, 'buy' is wrong; 'watch' is the only correct move. Avoid the high volatility and low volume. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.082821 |
| AutoETS | 0.083785 |
| AutoARIMA | 0.083786 |
| AutoTheta | 0.115447 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.25 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.234 |
| Excess Kurtosis | -0.86 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 71,552,840 |
| Forward P/E | -3.70 |
| Beta | 0.51 |
| Website | https://beyondspringpharma.com |
As of April 19, 2026, 6:33 p.m. EDT: Call volume and Open Interest (OI) are concentrated significantly in out-of-the-money strikes (2.5, 5.0, 7.5), hemming in OI between $1.73 (near-term high) and $7.50+. This creates a distinct upside bias or bullish gamma exposure, suggesting speculators are positioning for a hypothetical break of $1.73. Conversely, put activity is sparse and centered at the $2.50 strike, indicating limited hedging demand below the current price. The lack of data for May expiration calls suggests a lack of immediate interest in near-term rallies, but the presence of July calls creates a 'wall' at the $2.50 strike.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.30514705 |
| Address1 | 100 Campus Drive |
| Address2 | 4th Floor, Suite 410 West Side |
| All Time High | 48.49 |
| All Time Low | 0.542 |
| Ask | 1.61 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 10,030 |
| Average Daily Volume3 Month | 20,977 |
| Average Volume | 20,977 |
| Average Volume10Days | 10,030 |
| Beta | 0.506 |
| Bid | 1.48 |
| Bid Size | 1 |
| Book Value | -0.798 |
| City | Florham Park |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.74 |
| Current Ratio | 1.538 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.8 |
| Day Low | 1.68 |
| Display Name | BeyondSpring |
| Earnings Timestamp | 1,774,441,800 |
| Earnings Timestamp End | 1,778,616,000 |
| Earnings Timestamp Start | 1,778,616,000 |
| Ebitda | -8,858,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -7.782 |
| Enterprise Value | 68,930,016 |
| Eps Forward | -0.47 |
| Eps Trailing Twelve Months | -0.21 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.5594 |
| Fifty Day Average Change | 0.18060005 |
| Fifty Day Average Change Percent | 0.11581381 |
| Fifty Two Week Change Percent | 30.514706 |
| Fifty Two Week High | 3.44 |
| Fifty Two Week High Change | -1.7 |
| Fifty Two Week High Change Percent | -0.49418604 |
| Fifty Two Week Low | 1.21 |
| Fifty Two Week Low Change | 0.53 |
| Fifty Two Week Low Change Percent | 0.4380165 |
| Fifty Two Week Range | 1.21 - 3.44 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,489,069,800,000 |
| Float Shares | 31,689,400 |
| Forward Eps | -0.47 |
| Forward P E | -3.7021277 |
| Free Cashflow | 15,030,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 44 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14893 |
| Held Percent Institutions | 0.14559 |
| Implied Shares Outstanding | 41,122,320 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing Plinabulin in combination with docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that is has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey. |
| Long Name | BeyondSpring Inc. |
| Market | us_market |
| Market Cap | 71,552,840 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_409784135 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -8,473,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 73,000,016 |
| Open | 1.68 |
| Operating Cashflow | -19,769,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 646 305 6387 |
| Previous Close | 1.7753 |
| Price Hint | 4 |
| Price To Book | -2.1804512 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.925 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.035300016 |
| Regular Market Change Percent | -1.9883972 |
| Regular Market Day High | 1.8 |
| Regular Market Day Low | 1.68 |
| Regular Market Day Range | 1.68 - 1.8 |
| Regular Market Open | 1.68 |
| Regular Market Previous Close | 1.7753 |
| Regular Market Price | 1.74 |
| Regular Market Time | 1,776,788,500 |
| Regular Market Volume | 4,029 |
| Return On Assets | -0.18559 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 41,119,820 |
| Shares Percent Shares Out | 0.053400002 |
| Shares Short | 2,196,528 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,231,450 |
| Short Name | BeyondSpring, Inc. |
| Short Percent Of Float | 0.0644 |
| Short Ratio | 88.01 |
| Source Interval | 15 |
| State | NJ |
| Symbol | BYSI |
| Total Cash | 12,561,000 |
| Total Cash Per Share | 0.305 |
| Total Debt | 320,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.21 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.800125 |
| Two Hundred Day Average Change | -0.060124993 |
| Two Hundred Day Average Change Percent | -0.033400454 |
| Type Disp | Equity |
| Volume | 4,029 |
| Website | https://beyondspringpharma.com |
| Zip | 7,932 |